Structure optimization of a leukotriene D 4 antagonist by combinatorial chemistry in solution
Structure optimization of the leukotriene D 4 antagonist Ro24–5913 was attempted by combinatorial chemistry. Three segments in its N-succinyl-3-(2-thiazolylethenyl)anilide skeleton, designated as A, B, and C coincided with the thiazolyl, aniline, and N-acyl moieties, respectively, and were selected...
Saved in:
Published in | Bioorganic & medicinal chemistry Vol. 5; no. 3; pp. 493 - 496 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.03.1997
|
Online Access | Get full text |
Cover
Loading…
Summary: | Structure optimization of the leukotriene D
4 antagonist Ro24–5913 was attempted by combinatorial chemistry. Three segments in its
N-succinyl-3-(2-thiazolylethenyl)anilide skeleton, designated as A, B, and C coincided with the thiazolyl, aniline, and
N-acyl moieties, respectively, and were selected for variations in a synthesis involving the sequences A + B → AB and AB + C → ABC to furnish the library (
10A
7B
10C) containing 700 compounds. Lead candidates were identified by the LTD
4-induced muscle-contraction assay. Assays of the C-partition
10(
10A
7B C) of the set led to a subset of C elements associated with significant bioactivities, i
c = {C
1, C
2, C
3}, from which the preferred element C
1 was selected. Incorporating this selection into the synthesis of the first reduced set gave the partition
7(
10A B C
1) whose assay revealed the set i
B = {B
1, B
6} and hence the preferred B element B
1. The second reduced set,
10(A B
1 C
1) incorporating the selected C
1 and B
1 moieties, revealed i
A = {A
1, A
3, A
4, A
6, A
7, A
8, A
9}. In the resulting combinatorial product i
A × i
B × i
C, comprising 42 elements, A
1 B
1 C
1 appears on top of the list. Thus, 4-[[3-[2-[4-(2,2-dimethyl ethyl)cyclobutyl-2-thiazolyl]ethenyl] phenyl]amino]-2,2-diethyl-4-oxobutanoic acid (Ro24–5913) was confirmed as the structure with the highest bioactivity. Analogues obtained by replacement of the cyclobutyl group in Ro24–5913 with 4-fluorophenyl and
t-butyl were the runners-up. Of these, the former exhibited bioactivity comparable to that of Ro24–5913.
The optimum structural features were deduced by the introduction of molecular diversity at three sites followed by the evaluation of a library containing 700 compounds. |
---|---|
ISSN: | 0968-0896 1464-3391 |
DOI: | 10.1016/S0968-0896(96)00278-7 |